Laura Garcia De Freitas Souza > Machado Meyer Sendacz e Opice Advogados > São Paulo, Brazil > Lawyer Profile

Machado Meyer Sendacz e Opice Advogados
1052 – SÃO PAULO
SP 04534004

Work Department

Infrastructure and Energy




Laura Souza is specialist in energy law and in such area’s operations. Large part of Laura Souza’s work concerns legal assistance in structuring, legal support in the identification of the different models adopted in the electrical sector, legal assistance to foreign clients initiating activities in the country and legal assistance on regulatory energy law. Laura Souza has previous experience in providing legal assistance to clients, not only the ones originated from the energy sectors, in the areas of knowledge of generation, distribution, transmission and trading, but also in the energy-intensive industrial area, large size consumers and clients of several areas of knowledge that have the activity of power generation in their portfolios.


  • Brazilian Bar Association
  • Brazilian Institute for the Energy Law – IBDE


  • Universidade Cândido Mendes (Cândido Mendes University), Brazil (Bachelor of Laws, 1999)
  • Pontifícia Universidade Católica (Pontifical Catholic University) of São Paulo, Brazil (Postgraduation in Tax Law, 2003)
  • Fordham University School of Law, United States (Master’s degree in Commercial Law, 2008)

Lawyer Rankings

Brazil > Life sciences

The life sciences department at Machado Meyer Sendacz e Opice Advogados takes a multidisciplinary approach to advise and support its clients in the pharmaceutical and cosmetics industries, and also excels in advising companies in the tobacco, cannabis, and food and beverage sectors. Clients trust the firm to assist in navigating the Brazilian regulatory framework in the aforementioned sectors, as well as technology transfer agreements, clinical trials and research. The team is co-led by regulated market specialists Laura Garcia De Freitas Souza and Ana Karina Esteves de Souza. Gláucia Mara Coelho is also of note in the team, particularly in relation to regulatory agency disputes and strategic claims in the healthcare and pharmaceutical industries.